Co-founder & CEO, Escend Pharmaceuticals
Saira started her research career at Fox Chase Cancer Center and later held positions at Sterling Drug, Syntex, and Matrix Pharmaceuticals. Saira has provided preclinical support to several oncology programs, two of which are now marketed products, Treanda® and Synribo®. Saira has 10 issued and pending US patents. She has published her work in peer reviewed journals and presented at numerous scientific conferences. She has a BS in Biochemistry (Stony Brook University), MBA (Pepperdine University) and pursued post graduate studies at University of Pennsylvania and UC Berkeley.